Singapore’s biotechnology company, ImpacFat, has launched a new research and development center in Tokyo, Japan, marking their first international expansion beyond Singapore. The company has entered into a service contract with JR East to establish a shared office and laboratory at the Link Scholar’s Hub in Tokyo. This move is supported by strategic investments from major Japanese firms such as Toyo Seikan Group and Leave a Nest, signaling strong confidence in ImpacFat’s technology and growth potential.

ImpacFat is known for being the world’s first cultivated omega-3 fish fat company using stem-cell technology, aiming to replace traditional animal-derived fats with sustainable alternatives. The company holds an international patent for its core technology and has been recognized in the agri-foodtech sector, winning awards for their innovative approach. With a focus on addressing food security and providing healthy and sustainable options, ImpacFat’s expansion into Japan highlights their commitment to advancing sustainable food technologies and creating meaningful impact in both Singapore and Japan.